Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Daiichi Sankyo USDaiichi Sankyo US
VS
Astellas PharmaAstellas Pharma
Daiichi Sankyo US

Daiichi Sankyo US

211 Mt. Airy Road Basking Ridge, Basking Ridge, 07920, US

Last Update: 31/03/2026

View Profile
Between 800 and 849
https://daiichisankyo.us/
804/1000Good

At Daiichi Sankyo, we create essential medicine for longer, better lives. By uniting cutting edge science and technology with a genuine interest in people, we develop high quality, life changing solutions for the patients of today and tomorrow with great care and unwave...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:4,317
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0
Astellas Pharma

Astellas Pharma

N/A

Last Update: 24/09/2026

View Profile
Between 800 and 849
http://www.astellas.com/
800/1000Good

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and develo...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:12,597
Subsidiaries:1
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Daiichi Sankyo US

Daiichi Sankyo US

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Astellas Pharma

Astellas Pharma

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Daiichi Sankyo US in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Astellas Pharma in 2026.

Incidents

Incident History - Daiichi Sankyo US (X = Date, Y = Severity)

Daiichi Sankyo US cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Astellas Pharma (X = Date, Y = Severity)

Astellas Pharma cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Daiichi Sankyo US

Daiichi Sankyo US

Incidents
No explicit notable incidents reported.
Astellas Pharma

Astellas Pharma

Incidents
No explicit notable incidents reported.

FAQ

Between Daiichi Sankyo US company and Astellas Pharma company, which one has the best AI Cybersecurity Score ?
Between Daiichi Sankyo US company and Astellas Pharma company, which one has experienced more cyber incidents in the past ?
Between Daiichi Sankyo US company and Astellas Pharma company, which one has experienced more cyber incidents this year ?
Between Daiichi Sankyo US company and Astellas Pharma company, which one has experienced at least one ransomware attack ?
Between Daiichi Sankyo US company and Astellas Pharma company, which one has experienced at least one data breach ?
Between Daiichi Sankyo US company and Astellas Pharma company, which one has experienced at least one targeted cyberattack ?
Between Daiichi Sankyo US company and Astellas Pharma company, which one has experienced at least one vulnerability ?
Between Daiichi Sankyo US company and Astellas Pharma company, which one holds the most compliance certifications ?
Between Daiichi Sankyo US company and Astellas Pharma company, which one holds the fewest compliance certifications ?
Between Daiichi Sankyo US company and Astellas Pharma company, which one has the most subsidiaries ?
Between Daiichi Sankyo US company and Astellas Pharma company, which one has the largest number of employees ?
Between Daiichi Sankyo US and Astellas Pharma, which company holds both SOC 2 Type 1 certifications ?
Between Daiichi Sankyo US and Astellas Pharma, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Daiichi Sankyo US or Astellas Pharma ?
Which company is PCI DSS compliant - Daiichi Sankyo US or Astellas Pharma ?
Between Daiichi Sankyo US and Astellas Pharma, which company complies with HIPAA regulations for healthcare data ?
Between Daiichi Sankyo US and Astellas Pharma, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-111369
SUMMARY

ClassroomIO through 1.0.0 contains an incorrect authorization vulnerability in the PUT and DELETE /:lessonId lesson routes that allows any course member, including students, to modify lessons. Authenticated students can supply arbitrary lesson ids to change titles and stored HTML content or delete lessons in their course and in other courses and organizations.

PUBLISHED
Date2026-10-15
UPDATED
Date2026-10-15
RISK INFORMATION (Score: 7.1)
CVSS3
Base Score: 7.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:L
CVSS4
Base Score: 7.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:H/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
4.2
EXPLOITABILITY
2.8
CVE-2026-111368
SUMMARY

ClassroomIO through 1.0.0 contains an insecure direct object reference vulnerability in the Hono API course submission routes that allows course tutors or admins to modify submissions in other courses. Attackers can supply their own course id with another course's submission UUID to PUT or DELETE handlers to overwrite answers, grades, feedback, and grading status or delete submissions.

PUBLISHED
Date2026-10-15
UPDATED
Date2026-10-15
RISK INFORMATION (Score: 6.4)
CVSS3
Base Score: 6.4
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:H/A:L
CVSS4
Base Score: 6.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:L/UI:N/VC:L/VI:H/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
4.7
EXPLOITABILITY
1.6
CVE-2026-111367
SUMMARY

BillionMail through 4.9 contains a hard-coded cryptographic key vulnerability that allows unauthenticated attackers to forge unsubscribe and subscribe-confirm JWTs by computing the key from shipped configuration constants. Attackers can submit forged tokens to /api/unsubscribe, /api/unsubscribe_new, or /api/subscribe/confirm to deactivate any contact or force confirmed subscriptions.

PUBLISHED
Date2026-10-15
UPDATED
Date2026-10-15
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:L
CVSS4
Base Score: 6.9
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
2.5
EXPLOITABILITY
3.9
CVE-2026-111366
SUMMARY

cool-admin-midway through 8.0.0 contains an authorization bypass vulnerability that allows department-limited admins to manage users outside their departments by supplying arbitrary user ids. Attackers holding sys:user:* permissions can call /admin/sys/user/info, update, or delete to read records, reset passwords and roles, or delete accounts.

PUBLISHED
Date2026-10-15
UPDATED
Date2026-10-15
RISK INFORMATION (Score: 7.2)
CVSS3
Base Score: 7.2
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H
CVSS4
Base Score: 8.6
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
1.2
CVE-2026-111365
SUMMARY

cool-admin-midway through 8.0.0 contains an authorization bypass vulnerability that allows non-superadmin admins to read, modify, or delete other admins' roles by supplying arbitrary role ids. Attackers holding ordinary sys:role permissions can call /admin/sys/role/info, update, or delete with another admin's role id to rewrite menu and department grants, changing other users' effective access.

PUBLISHED
Date2026-10-15
UPDATED
Date2026-10-15
RISK INFORMATION (Score: 6)
CVSS3
Base Score: 6.0
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:L/I:H/A:L
CVSS4
Base Score: 7.0
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:L/VI:H/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
4.7
EXPLOITABILITY
1.2